Trial intelligence / Profile preview

Etomidate Combined With Propofol for Sedation in High-Altitude Gastroscopy

NCT07079176Not yet recruiting

Sponsor
Renji Hospital
Start
Aug 2025
Primary completion
Aug 2027
Modality
Small Molecules
01

Overview

Randomised trial of etomidate in gastrointestinal endoscopy (2 arms), sponsored by Renji Hospital. Primary endpoint: Risk of hypoxemia. Planned start Aug 2025; status: not yet recruiting.

02

Drugs

etomidate
03

Conditions

gastrointestinal endoscopy

Beyond the preview

Go deeper on NCT07079176.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07079176.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call